ClinicalTrials.gg
CompletedNCT06568146Updated Oct 29, 2024

A Single Group Study to Evaluate the Effects of a Multivitamin on a Range of Health and Wellbeing Outcomes.

An interventional study of Multivitamin Supplement in Health and Wellbeing, sponsored by Love Wellness. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-29.

Sponsored by Love Wellness · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

This is a hybrid single-group clinical trial that will last 12 weeks. Participants will take 2 capsules daily with the first meal of the day in the morning. Participants will undertake blood tests at Baseline and Week 12. Study-specific questionnaires will be completed at Baseline, Week 4, Week 8, and Week 12. Cognitive Battery Testing will take place at Baseline, Week 4, Week 8, and Week 12.

02

Conditions studied

  • Health and Wellbeing

Browse trials for

Keywords

  • Multivitamin
  • Cognitive Function
  • Iron
  • Vitamin D
  • Vitamin B12
  • Insulin
03

In context

Insulin Resistance

2,969 studies on the registry are indexed under Insulin Resistance; 338 are open to participants now.

This study's enrollment of 40 is close to the median of 40 across 2,369 interventional studies indexed under Insulin Resistance.

Browse Insulin Resistance studies →

Lead sponsor

Love Wellness is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female at birth.
  • Aged 18+.
  • Interested in supporting their health and wellbeing.
  • Not planning to introduce or change prescription medications, vitamins, minerals, or supplements one month prior to and during the study.
  • Generally healthy with no uncontrolled chronic conditions.

Exclusion criteria

Exclusion Criteria:

  • Recent surgeries or invasive treatments.
  • Introduction of new health-related products in the last 12 weeks.
  • Allergies to product ingredients or use of Epi-Pen.
  • Chronic health conditions affecting participation.
  • Endocrine or glucose-related disorders, including diabetes.
  • Hematological disorders, including anemia.
  • Pregnant, breastfeeding, or planning to conceive.
  • History of substance abuse or recent smoking.
  • Unwillingness to follow the study protocol.
  • Participation in other clinical trials.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Multivitamin Supplement Group

    Participants in this arm will take 2 capsules of the multivitamin supplement daily with the first meal of the day in the morning.

    Dietary Supplement: Multivitamin Supplement

Interventions

  • Dietary supplementMultivitamin Supplement

    : Participants will take 2 capsules of the multivitamin supplement daily with the first meal of the day in the morning.

    Also known as: Daily Love Multivitamin

06

What researchers measure

Primary outcomes

  1. Changes in Blood Levels of Vitamin B12

    This outcome measure will assess the effect of the multivitamin supplement on serum levels of Vitamin B12.

    Time frame: Baseline and Week 12

  2. Changes in Blood Levels of Insulin

    This outcome measure will assess the effect of the multivitamin supplement on serum levels of Insulin.

    Time frame: Baseline and Week 12

  3. Changes in Blood Levels of Vitamin D

    This outcome measure will assess the effect of the multivitamin supplement on serum levels of Vitamin D.

    Time frame: Baseline and Week 12

  4. Changes in Blood Levels of Iron

    This outcome measure will assess the effect of the multivitamin supplement on serum levels of Iron.

    Time frame: Baseline and Week 12

Secondary outcomes

  1. Participants' Perceptions of Health and Wellbeing

    Evaluation of participants' perceptions via a questionnaire exploring the convenience and efficacy of the multivitamin supplement in supporting overall health and wellbeing.

    Time frame: Baseline, Week 4, Week 8, and Week 12

07

Study locations

1 site
  • Citruslabs
    Santa Monica, California 90404, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2024 to primary completion in Oct 2024, 5 months.

Of 40 industry-sponsored interventional studies with no phase under Insulin Resistance, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 22. This study's 5 months is below that.

Counting every sponsor, half of 754 studies reached it within 21 months; a quarter within 9 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 11, 2024
First posted
Aug 23, 2024
StartActual
May 23, 2024
Primary completionActual
Oct 23, 2024
CompletionActual
Oct 23, 2024
Last update
Oct 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06568146
Lead sponsor
Love Wellness
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Aug 23, 2024
Start date
May 23, 2024
Primary completion
Oct 23, 2024
Completion
Oct 23, 2024
Last update
Oct 29, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion